ATYR
aTyr Pharma
ATYR
ATYR
29 hedge funds and large institutions have $33.8M invested in aTyr Pharma in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 25 → 29 (+4)
6.14% more ownership
Funds ownership: 36.92% → 43.05% (+6.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
29
Holding in Top 10
1
Calls
$96K
Puts
$12K
Top Buyers
| 1 | +$1.46M | |
| 2 | +$1.42M | |
| 3 | +$764K | |
| 4 |
Two Sigma Advisers
New York
|
+$516K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$445K |
Top Sellers
| 1 | -$321K | |
| 2 | -$292K | |
| 3 | -$139K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$80.1K |
| 5 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
-$63K |